CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...